The EU MedTech Innovation Pressure: Navigating 2026 "Crunch" and EY-DG SANTE Findings For years, the European Union was the global launchpad for EU MedTech Innovation, but recent data suggests a pivotal identity crisis is looming. A "CE Mark" was often the first major milestone for a startup before tackling the FDA. However, the tide has turned. As we move deeper into the mid-2020s, the medical technology landscape is facing a pivotal identity crisis. The recent EY-DG SANTE study , commissioned by the European Commission, has provided the data to back up what many MedTech professionals have been whispering in boardrooms: the regulatory burden of the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) is creating an "innovation drain." The Data Speaks: Key Findings from the EY-DG SANTE Study The study was designed to monitor the availability of medical devices on the EU market. The results are a wake-up call. According to the ...
Updated in 2026 – This article reflects the latest developments in blockchain, healthcare interoperability, AI integration, and global regulatory trends. The healthcare industry is undergoing a fundamental shift toward digital-first, data-driven care. As electronic health records, AI diagnostics, and remote care expand, the need for secure, interoperable, and trustworthy data management has never been greater. In 2026, blockchain technology is emerging as a foundational layer for healthcare data management , not as a trend, but as an infrastructure solution. What Is Blockchain in Healthcare? Blockchain is a decentralized, cryptographically secured digital ledger that records transactions across multiple nodes. In healthcare, blockchain is primarily used to: Secure patient health data Enable interoperable data exchange Manage patient consent Track pharmaceutical supply chains Maintain clinical trial data integrity Unlike public cryptocurrency networks, ...